Document is current
Any future updates will be listed below
-
Authors
Cronstein, Bruce N. http://orcid.org/0000-0002-4295-7383
Aune, Thomas M. http://orcid.org/0000-0002-4968-4306
- License Information
-
More Information
Article History
Accepted: 10 January 2020
First Online: 17 February 2020
Competing interests
: B.N.C. declares that he holds equity in Regenosine, a biotech start-up developing therapies for osteoarthritis, and CanFite Biopharma, that he has received grant support from AstraZeneca and Kairos Inc., and that he has a number of patents involving adenosine receptors and hepatic fibrosis, wound healing, bone regeneration and osteoarthritis. T.M.A. declares that he has no competing interests.
